Zoetis (ZTS) Acquires Ethos Diagnostic Science
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Zoetis Acquires Ethos Diagnostic Science, a Veterinary Reference Lab Business, to Further Expand its Comprehensive Diagnostics Capabilities
February 7, 2020 4:30 PM ESTThe addition of three lab locations complements Zoetis growing reference laboratory footprint and enhances its value to veterinarians in the U.S.
PARSIPPANY, N.J. & WOBURN, Mass.--(BUSINESS WIRE)-- Zoetis Inc. (NYSE: ZTS) today announced the acquisition of Ethos Diagnostic Science, a veterinary reference lab business dedicated to serving leading specialty animal hospitals,... More
